# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-001076
Filing Date
2026-01-06
Accepted
2026-01-06 07:15:11
Documents
42
Period of Report
2026-01-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | acrs-20260106x8k.htm iXBRL | 8-K | 56022
2 | EX-99.1 | acrs-20260106xex99d1.htm | EX-99.1 | 28539
3 | EX-99.2 | acrs-20260106xex99d2.htm | EX-99.2 | 39132
4 | GRAPHIC | acrs-20260106xex99d1001.jpg | GRAPHIC | 5588
5 | GRAPHIC | acrs-20260106xex99d1002.jpg | GRAPHIC | 12836
6 | GRAPHIC | acrs-20260106xex99d2g001.jpg | GRAPHIC | 123896
7 | GRAPHIC | acrs-20260106xex99d2g002.jpg | GRAPHIC | 250727
8 | GRAPHIC | acrs-20260106xex99d2g003.jpg | GRAPHIC | 134432
9 | GRAPHIC | acrs-20260106xex99d2g004.jpg | GRAPHIC | 143650
10 | GRAPHIC | acrs-20260106xex99d2g005.jpg | GRAPHIC | 122049
11 | GRAPHIC | acrs-20260106xex99d2g006.jpg | GRAPHIC | 136734
12 | GRAPHIC | acrs-20260106xex99d2g007.jpg | GRAPHIC | 112533
13 | GRAPHIC | acrs-20260106xex99d2g008.jpg | GRAPHIC | 185351
14 | GRAPHIC | acrs-20260106xex99d2g009.jpg | GRAPHIC | 114877
15 | GRAPHIC | acrs-20260106xex99d2g010.jpg | GRAPHIC | 146591
16 | GRAPHIC | acrs-20260106xex99d2g011.jpg | GRAPHIC | 152094
17 | GRAPHIC | acrs-20260106xex99d2g012.jpg | GRAPHIC | 134629
18 | GRAPHIC | acrs-20260106xex99d2g013.jpg | GRAPHIC | 137875
19 | GRAPHIC | acrs-20260106xex99d2g014.jpg | GRAPHIC | 117754
20 | GRAPHIC | acrs-20260106xex99d2g015.jpg | GRAPHIC | 153597
21 | GRAPHIC | acrs-20260106xex99d2g016.jpg | GRAPHIC | 110752
22 | GRAPHIC | acrs-20260106xex99d2g017.jpg | GRAPHIC | 119989
23 | GRAPHIC | acrs-20260106xex99d2g018.jpg | GRAPHIC | 90899
24 | GRAPHIC | acrs-20260106xex99d2g019.jpg | GRAPHIC | 80372
25 | GRAPHIC | acrs-20260106xex99d2g020.jpg | GRAPHIC | 122577
26 | GRAPHIC | acrs-20260106xex99d2g021.jpg | GRAPHIC | 162129
27 | GRAPHIC | acrs-20260106xex99d2g022.jpg | GRAPHIC | 179829
28 | GRAPHIC | acrs-20260106xex99d2g023.jpg | GRAPHIC | 148810
29 | GRAPHIC | acrs-20260106xex99d2g024.jpg | GRAPHIC | 196598
30 | GRAPHIC | acrs-20260106xex99d2g025.jpg | GRAPHIC | 126418
31 | GRAPHIC | acrs-20260106xex99d2g026.jpg | GRAPHIC | 123891
| Complete submission text file | 0001104659-26-001076.txt |  | 5272682

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
32 | EX-101.SCH | acrs-20260106.xsd | EX-101.SCH | 2680
33 | EX-101.LAB | acrs-20260106_lab.xml | EX-101.LAB | 15911
34 | EX-101.PRE | acrs-20260106_pre.xml | EX-101.PRE | 10218
44 | EXTRACTED XBRL INSTANCE DOCUMENT | acrs-20260106x8k_htm.xml | XML | 4792

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 26509394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)